The Effect of Yogurt Containing BB12 on Children's Health and Child Care Absenteeism
Not Applicable
Completed
- Conditions
- Children's Health and GrowthChildcare Absenteeism
- Registration Number
- NCT00653705
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Brief Summary
The aim of our study is to assess the effect of daily consumption of yogurt containing probiotic bacteria BB12 on the health and growth of healthy children 12-48 months of age in out of home child care.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 181
Inclusion Criteria
- An informed consent has been signed by the parents.
- The child is at least one year old and has not had his 4th birthday at the beginning of the study
- The child is healthy.
- The child attends child care center at least 5 days a week, > 4 hours per day.
Exclusion Criteria
- Was born preterm.
- Had a birth weight <2,500 g.
- Has congenital anomalies.
- Has a structural abnormality of the digestive tract or previous significant gastrointestinal surgery.
- Has chronic disease or malignancy.
- Has a serious, unstable medical condition.
- Is Failure to Thrive (FTT) (<5th percentile of ideal body weight).
- Has an allergy or atopic disease.
- Has an allergy or intolerance to milk/dairy products.
- Has an established diagnosis of lactase deficiency.
- Is predisposed to infection (i.e., compromised immune system, HIV-AIDS, active bacterial disease, under steroid treatment).
- Received antibiotic treatment or intentionally consumes probiotic products during the preceding 4 weeks. (If the subject was on antibiotics before the beginning of the study or probiotics, a washout period of 2 weeks is required.)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Days of illness symptoms, number, duration and severity of illness episodes, day care absenteeism, and parental work absenteeism 16 weeks
- Secondary Outcome Measures
Name Time Method Health care utilization and illness related costs as measured by number of physician visits, ER visits, hospitalizations, and antibiotics use. Also, child growth and quality of life. Exploratory biomarker outcomes in stool. 16 weeks
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms by which Bifidobacterium lactis BB12 influences immune development in early childhood?
How does probiotic BB12 compare to other Lactobacillus strains in reducing childcare absenteeism due to infections?
What biomarkers correlate with improved growth outcomes in children consuming BB12-containing yogurt?
What are the safety profiles of Bifidobacterium lactis BB12 in pediatric populations with normal immune function?
How does BB12 probiotic supplementation affect gut microbiota composition in 12-48 month old children in daycare settings?
Trial Locations
- Locations (1)
University of North Carolina at Chapel Hill, School of Public Health
🇺🇸Chapel Hill, North Carolina, United States
University of North Carolina at Chapel Hill, School of Public Health🇺🇸Chapel Hill, North Carolina, United States